This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Urofollitropin
Description: Bravelle is a highly purified preparation of human follicle-stimulating hormone (FSH), containing 75 IUs FSH with 2% luteinizing hormone (LH) activity. Bravelle is used for the induction of ovulation and to stimulate the development of multiple follicles in Assisted Reproductive Technology (ART).
Pink Sheet Bravelle approval (correction)
Pink Sheet Ferring Bravelle approved
Pink Sheet Ferring Bravelle in vitro use
Pink Sheet Ferring Bravelle approval
Additional information available to subscribers only: